Press Releases


Media Contact:
Stephen Majors
Director, Public Affairs
smajors@alliancerm.org


Media Contact:
Stephen Majors
Director, Public Affairs
smajors@alliancerm.org

Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments

March 24, 2021

BRUSSELS, BELGIUM

The Alliance for Regenerative Medicine (ARM) – the global voice of the regenerative medicine and advanced therapies sector – welcomes the Council of the European Union’s support for EU-level joint clinical assessments. If adopted, joint clinical assessments can eliminate duplicative reviews of transformative Advanced Therapy Medicinal Products (ATMPs) across member states, reducing the time and cost required to bring durable, and potentially curative, cell, gene, and tissue-based therapies to patients anywhere in the EU.


Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020

March 16, 2021

Washington, DC

The regenerative medicine and advanced therapies sector raised a record $19.9B in funding in 2020, fueling the broader biotech sector and driving a rapidly advancing pipeline of potentially transformative therapies, according to the Alliance for Regenerative Medicine’s (ARM) 2020 Annual Report released today.


Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan

February 3, 2021

WASHINGTON, DC and BRUSSELS, BELGIUM

The Alliance for Regenerative Medicine (ARM) – the ‘global voice’ of the regenerative medicine and advanced therapies sector – applauds the EU Beating Cancer Plan’s identification of Advanced Therapy Medicinal Products (ATMPs) as part of a comprehensive cancer solution. ATMPs include cell and gene therapies that have already revolutionized the treatment of some aggressive forms of blood cancers and hold great promise for addressing other types of cancer.


ARM Statement on the Trump Administration's Interim Final MFN Rule

January 26, 2021

Washington, DC